Emerging market managers have highlighted the added value of incorporating ESG criteria into their investment processes, as research shows this has been a stronger source of stock specific alpha for funds investing in the region compared to developed counterparts.
According to a recent report entitled The Value of ESG Data: Early Evidence for Emerging Markets Equities, written by investment consultancy firm Cambridge Associates, the MSCI EM ESG index outperformed...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds